NFE2L2 and Parkinson disease: In PC12/α-syn cells and MPTP-induced PD animal models, SDA was highly efficacious in α-syn clearance associated with the activation of antioxidant PGC-1α/Nrf2 signal pathway, indicating it a potential therapeutic drug for PD.